Nexalin Technology (NXL) Research & Development (2024 - 2026)
Nexalin Technology (NXL) posted Research & Development of $564480.0 for Q2 2026, up 62.96% on a QoQ basis from $346382.0 in Q1 2026, and up 150.02% year-over-year from $225774.0 in Q2 2025.
Powered by 
Analysis
Nexalin Technology (NXL) Research & Development (2024 - 2026) Analysis & Trends
Nexalin Technology has reported Research & Development for 3 years, with the latest figure at $564480.0 in Q2 2026.
- On a quarterly basis, Research & Development rose 150.02% year-over-year to $564480.0 in Q2 2026; TTM through Jun 2026 was $1.4 million, a 11.99% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 9.02% from the prior year.
- Research & Development was $564480.0 for Q2 2026 at Nexalin Technology, up from $346382.0 in the prior quarter.
- The five-year high for Research & Development was $737242.0 in Q4 2024, with the low at $105668.0 in Q1 2024.
- Average Research & Development over 3 years is $318526.9, with a median of $226147.0 recorded in 2025.
- The largest YoY upside for Research & Development was 284.49% in 2025 against a maximum downside of 69.49% in 2025.
- Over 3 years, Research & Development stood at $737242.0 in 2024, then plunged by 69.49% to $224940.0 in 2025, then soared by 150.95% to $564480.0 in 2026.
- The last three Research & Development figures came in at $564480.0 (Q2 2026), $346382.0 (Q1 2026), and $224940.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | -663.00 Mn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | 153.00 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 | 564,480.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 564,480.00 |
| Mar 31, 2026 | 346,382.00 |
| Dec 31, 2025 | 224,940.00 |
| Sep 30, 2025 | 226,520.00 |
| Jun 30, 2025 | 225,774.00 |
| Mar 31, 2025 | 406,288.00 |
| Dec 31, 2024 | 737,242.00 |
| Sep 30, 2024 | 178,565.00 |
| Jun 30, 2024 | 169,410.00 |
| Mar 31, 2024 | 105,668.00 |